Deanna L. Kirkpatrick

Davis Polk advised the joint book-running managers in connection with the $97.75 million initial public offering of 9,775,000 units of Turmeric Acquisition Corp., which includes 1,275…

Davis Polk advised the underwriters in connection with the offering of $1.25 billion aggregate principal amount of 1.125% bonds due October 7, 2030 issued by the Province of Ontario. The…

Davis Polk advised VG Acquisition Corp. on its $480 million initial public offering of 48,000,000 units. Each unit had an initial offering price of $10 and consists of one Class A ordinary…

Davis Polk advised the underwriters in connection with the $575 million initial public offering of 57,500,000 units of Vy Global Growth, which includes 7,500,000 units from the full…

Davis Polk advised the representatives of the underwriters in connection with the initial public offering of 40,000,000 units of AEA-Bridges Impact Corp. for aggregate proceeds of $400…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering of 5,750,000 common shares of Beam Therapeutics Inc. for total gross proceeds of $127…

Davis Polk advised the representatives of the several underwriters, in connection with the initial public offering of 23,000,000 units of Climate Change Crisis Real Impact I…

Davis Polk advised the representatives of the several underwriters in connection with the initial public offering of 33,000,000 units of Qell Acquisition Corp., for aggregate proceeds…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of €6.25 billion aggregate principal amount of notes by Medtronic Global…

 Davis Polk advised ADC Therapeutics SA on its SEC-registered offering of 6,000,000 common shares for total gross proceeds of $204 million. ADC Therapeutics is listed on the New York…